glp-1 drugs and hashimoto's receptor agonists GLP-1 for Weight Loss and

Patients often experience improvements in mobility, mood, and energy levels, which lead to improved health outcomes and a higher quality of life

41,42 Post-transcriptionally, several miRNAs, including miR-34a, 43 miR-132, 44 and miR-217, 45 target the 3 untranslated region of SIRT1 mRNA and inhibit translation

The primary constituent, glutathione, is a paramount antioxidant that neutralizes harmful free radicals responsible for cellular impairment

Common side effects for both include: Mild injection-site reactions (small bump or redness, resolves within hours) Transient water retention in the first 1-2 weeks Vivid dreams in the first week (often a positive sign of deepening REM cycles) Occasional brief flushing sensation immediately after injection more common with CJC-1295/Ipamorelin Mild tingling or fatigue in the first few doses, typically resolves quickly Less common but serious considerations include effects on glucose tolerance (worth monitoring if you're insulin-resistant or diabetic), the potential for joint discomfort if dose is too high, and any contraindications related to active cancer, severe pituitary issues, or specific medications

In DKD patients, gemigliptin treatment significantly suppressed the expression of renal tubular injury biomarkers and the levels of vascular calcification markers (187)

1995 Sep;2(4):357-62